Novartis (NVS) Stock
Novartis (NVS) closed at $159.13 on Nov 17, 2026; its Tenet Score is 55 of 100 against 340 Healthcare peers.
6 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $159.13
- Nov 17, 2026
- Market cap
- $305.7B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 21.9×
- fiscal year to Dec 31, 2025 · as of close, Nov 16, 2026
- Dividend yield
- 2.96%
- past year's regular dividends ÷ price · as of close, Nov 16, 2026
- 52-week range
- 123.24 – 170.46
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 55/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Novartis AG scores 55/100. Mixed. Strongest on quality, financial health is the soft spot, trading at 22× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ✓ Piotroski F-Score
- ~ Magic Formula
- ✕ Graham Defensive
- ✕ Lynch GARP
- ~ Income & Dividend Safety
Pays 2.96% · 80% of earnings, fiscal 2025. Yield is one component of total return.
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Johnson & JohnsonJNJ | 48 | $680.2B |
| Abbvie IncABBV | 42 | $520.7B |
| Merck & Co IncMRK | 41 | $356.1B |
| AMGEN Inc.AMGN | 47 | $250.1B |
| Gilead Sciences, Inc.GILD | 38 | $207.9B |
| Novo NordiskNVO | 62 | $185.7B |
| Pfizer Inc.PFE | 50 | $164.5B |
| Vertex Pharmaceuticals, Inc.VRTX | 55 | $136.4B |
| Bristol-Myers Squibb Co.BMY | 51 | $128.6B |
| GSK PlcGSK | 51 | $108.8B |
Compare Novartis with
Common questions
What sector and industry is Novartis in?
Novartis is in the Healthcare sector and the Drugs industry.
What is Novartis' Tenet Score?
Novartis' Tenet Score is 55 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




